liver function after major hepatectomy

A total of 218 patients diagnosed with HCC who underwent major hepatectomy were finally enrolled for this study. The patients received different vasoactive agents after hepatectomy. They were divided into three intervention groups: terlipressin (n = 64), somatostatin (n = 48), and combination (terlipressin+somatostatin, n = 34), and a control group (n = 72), In this EXCEL prolie, including sex, age, diabetes, HBsAg, preoperative parameters (albumin, PT, TB, ascites, cirrhosis), number of tumors, total diameter of tumors, segments of resection, and intraoperative bleeding. liver function (alanine transaminase [ALT], PT, and TB levels on POD 1, 3, and 5, and their peak levels) and ascites were analyzed.